Head and Neck Cancer News & Features

Using ESAs in patients with cancer-related anemia

Sarah Wenger, PharmD; Lisa A. Thompson, PharmD, BCOP January 13, 2012

Although the risks of erythropoietin-stimulating agents can outweigh the benefits, select patients may benefit from these drugs.
 

New approach improves skull-base tumor surgery

December 16, 2011

A new transvestibular endoscopic method for removing tumors at the base of skull features shorter operation and recovery periods, fewer complications, and no scars.
 

MRI gives SWIFT preoperative indication of jawbone disease in oral cancer

Delicia Honen Yard October 20, 2011

The often difficult task of detecting whether advanced squamous cell carcinoma in the oral cavity has invaded the mandible may be made easier with an MRI technique known as SWIFT.
 

Oncology Nurse Advisor Forum - July/August 2011

August 01, 2011

Based on associations between HPV and head and neck cancer, what public health initiatives should be implemented? What is the significance of food-drug interactions with oral TKIs?
 

Current alcohol consumption guidelines will not prevent cancer

Delicia Honen Yard July 27, 2011

An analysis published online by CMAJ charges that current guidelines for alcohol consumption are inadequate for cancer prevention and that new international guidelines are needed.
 

Experts discuss their predictions for radiation medicine

Bryant Furlow July 08, 2011

Presentations on emerging standards of care in radiotherapy from the Future of Radiation Medicine 2011 symposium are reviewed.
 

Study identifies patients best suited to second round of head-and-neck treatment

Delicia Honen Yard June 30, 2011

A small group of patients with recurrent or second primary head and neck cancer achieved long-term cure after undergoing concomitant chemotherapy with reirradiation.
 

HHS adds eight substances to list of carcinogens

Delicia Honen Yard June 27, 2011

The US Department of Health and Human Services (HHS) has added eight substances to its 12th Report on Carcinogens, bringing the number of entries on the list to 240.
 

"FATE" survey assesses end of life in head and neck cancer

Delicia Honen Yard May 12, 2011

Palliative treatments, death outside of the hospital, and involvement by a palliative care team all improve the end-of-life experience for persons with head and neck cancer.
 

AIDS raises risk for stomach and esophageal malignancies

Delicia Honen Yard April 21, 2011

A large study showed that people with AIDS are 6.9-fold more likely than the general population to develop stomach malignancies and 2.7 times more likely to have esophageal malignancies.
 

Head and Neck Cancer Clinical Trials

Clinical Trial: Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer

Clinical Trial: Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers

Clinical Trial: Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

Clinical Trial: Comprehensive Assessment of Head and Neck Cancer Survivors (CAHNCA)

Clinical Trial: Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Cancer care is expensive.
CancerCare can help.


Connect Booklets

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions